Hall, R. P., Streilein, R. D., Hannah, D. L., McNair, P. D., Fairley, J. A., Ronaghy, A., … Levesque, M. C. (2013). Association of serum B-cell activating factor level and proportion of memory and transitional B cells with clinical response after rituximab treatment of bullous pemphigoid patients. J Invest Dermatol, 133(12), 2786–2788. https://doi.org/10.1038/jid.2013.236

Hall, Russell P., Robert D. Streilein, Deborah L. Hannah, Patrice D. McNair, Janet A. Fairley, Arash Ronaghy, Kim D. Edhegard, and Marc C. Levesque. “Association of serum B-cell activating factor level and proportion of memory and transitional B cells with clinical response after rituximab treatment of bullous pemphigoid patients.” J Invest Dermatol 133, no. 12 (December 2013): 2786–88. https://doi.org/10.1038/jid.2013.236.

Hall RP, Streilein RD, Hannah DL, McNair PD, Fairley JA, Ronaghy A, et al. Association of serum B-cell activating factor level and proportion of memory and transitional B cells with clinical response after rituximab treatment of bullous pemphigoid patients. J Invest Dermatol. 2013 Dec;133(12):2786–8.

Hall, Russell P., et al. “Association of serum B-cell activating factor level and proportion of memory and transitional B cells with clinical response after rituximab treatment of bullous pemphigoid patients.” J Invest Dermatol, vol. 133, no. 12, Dec. 2013, pp. 2786–88. Pubmed, doi:10.1038/jid.2013.236.

Hall RP, Streilein RD, Hannah DL, McNair PD, Fairley JA, Ronaghy A, Edhegard KD, Levesque MC. Association of serum B-cell activating factor level and proportion of memory and transitional B cells with clinical response after rituximab treatment of bullous pemphigoid patients. J Invest Dermatol. 2013 Dec;133(12):2786–2788.